Phase 1 HPV 16+ Recurrent or Metastatic Cancer Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Safety and Efficacy of Allogeneic HPV-specific T Cells in Adults With Recurrent or Metastatic HPV16+ Cancers

HPV 16+ Recurrent or Metastatic Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins24 enrolled1 locationNCT04713046

Recruiting

Phase 1

Study of TI-0093 Injection With Recurrent/Metastatic HPV-16 Positive Solid Tumors

Cervical CancerHNSCCHPV 16+ Recurrent or Metastatic Cancer

Therorna12 enrolled1 locationNCT07081984